“Lysate” comes from the Latin word lysis, which translates as “to break open.” So Platelet Lysate is made up of platelets that have been broken open in some way. Platelets contain alpha granules, which are small packets where their growth factors live. When you break open a platelet, the growth factors are released all at once rather than being released over a longer term. As a result, you can benefit from a higher dose of growth factors, in a shorter period of time, with a platelet lysate (PL) than if you used platelet-rich plasma (PRP). Similar to an immediate release pill, which releases a drug more quickly than a sustained release pill that releases a drug over a longer timeframe.
Platelet Lysate is made possible by utilizing a flexible Regenexx lab platform, which allows us to customize our regenerative orthopedic solutions to best meet the patient’s needs.
Video: Regenexx Super Concentrated Platelet Rich Plasma vs. Platelet Lysate
PRP, or platelet-rich plasma, is a good solution for treating mild arthritis in joints, ligament tears, or small tendons. We’ve found that Platelet Lysate has preferred characteristics for use around nerves. For this reason, it is used extensively in the spine, where we encounter irritated nerves due to disc bulges. It’s also a useful option for treating nerve-related issues like carpal tunnel syndrome, or other similar types of conditions. To see how Regenexx-PL is used there, watch the video below, which shows a precision, ultrasound-guided, nerve hydrodissection.
Video: Precise Hydrodissection Using Ultrasound Guidance
Regenexx® Procedures provide non-surgical treatment options for those suffering from pain related to osteoarthritis, joint injuries, spine pain, overuse conditions, and common sports injuries. These medical procedures are only performed by highly-skilled doctors and are used to help reduce pain and improve function. Regenexx procedures have helped thousands of patients improve their quality of life, return to the activities they enjoy, and avoid the need for surgery or joint replacement*.
Regenexx Physicians represent a very selective, highly-skilled, interventional orthobiologics network that is 100% focused on orthopedic conditions. All Regenexx physicians are musculoskeletal experts with extensive training and experience in the diagnosis and treatment of musculoskeletal conditions, as well as complex, image-guided injections of your body's own healing agents to treat orthopedic issues. Regenexx patient outcomes are tracked in a registry and with that information, we provide transparent outcome data (below) for those who may be considering this treatment option.
Want to find out if you are a Regenexx Candidate? Complete the Candidate Form.
Video Case Study: How the Regenexx Flexible Lab Platform Allows for Customization and Optimal Patient Outcomes.
Regenexx is unique in that it maintains an active patient registry that continually pings patients about their progress or side effects post-procedure. As a result, we keep records on tens of thousands of Regenexx procedures performed by physicians in our network in our outcomes database. Regenexx is the only company that has tracked an orthopedic patient population of this size, who were treated with bone marrow concentrate.
In our effort to be completely transparent with potential patients, we make these results available through our website. You can see for yourself how many procedures we’re tracking and the results patients have reported. With Regenexx, you have the tools you need to make an informed decision about what treatment option is right for you.
There are more than 3662 Regenexx cervical spine patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 53% of their optimal function. After receiving treatment, they report averages up to 73%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.8/10. One month after treatment, pain levels decrease to an average of 3.3/10, a decrease of 31%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 38% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 1326 Regenexx elbow patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 69% of their optimal function. After receiving treatment, they report averages up to 95%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.2/10. One month after treatment, pain levels decrease to an average of 2.8/10, a decrease of 33%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 38% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 1060 Regenexx ankle & foot patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 56% of their optimal function. After receiving treatment, they report averages up to 73%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.6/10. One month after treatment, pain levels decrease to an average of 2.9/10, a decrease of 37%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 26% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 556 Regenexx hand & wrist patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 65% of their optimal function. After receiving treatment, they report averages up to 85%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.5/10. One month after treatment, pain levels decrease to an average of 2.9/10, a decrease of 36%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 30% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 2616 Regenexx hip patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 49% of their optimal function. After receiving treatment, they report averages up to 76%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.9/10. One month after treatment, pain levels decrease to an average of 3.4/10, a decrease of 31%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 33% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 12729 Regenexx knee patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 55% of their optimal function. After receiving treatment, they report averages up to 74%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.2/10. One month after treatment, pain levels decrease to an average of 2.3/10, a decrease of 45%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 37% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 11176 Regenexx lumbar spine patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 49% of their optimal function. After receiving treatment, they report averages up to 71%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.8/10. One month after treatment, pain levels decrease to an average of 3.4/10, a decrease of 29%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 35% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.
There are more than 2636 Regenexx shoulder patients being tracked in the Regenexx® Patient Registry.
Quick Links
Prior to treatment, patients report being limited to an average of 65% of their optimal function. After receiving treatment, they report averages up to 87%. The functional questionnaire represented here is the Functional Rating Index (FRI).
Data updated September 7, 2021.
Prior to receiving treatment, patients report average pain of 4.3/10. One month after treatment, pain levels decrease to an average of 2.8/10, a decrease of 35%. The questionnaire used is the Numeric Pain Scale (NPS).
Data updated September 7, 2021.
Patients feel their joints are, on average, already 28% better after only 1-month, and continue to improve from there. The questionnaire used is the Single Assessment Numeric Evaluation (SANE).
Data updated September 7, 2021.